Epimune

Epimune is a startup based in Berlin, Germany. Its most recent tracked round is Pre-Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Epimune develops and commercializes molecular diagnostic tests that use epigenetic analysis to quantify immune cells from a drop of blood collected via finger prick and dried on filter paper, enabling early diagnosis and monitoring of immune system disorders.